• 1
    Gottesman MM, Fojo T, Bates SE. Multidrug resistance in cancer: role of ATP-dependent transporters. Nat Rev Cancer 2002; 2: 4858.
  • 2
    Borst P, Evers R, Kool M, Wijnholds J. A family of drug transporters: the multidrug resistance-associated proteins. J Natl Cancer Inst 2000; 92: 1295302.
  • 3
    Lage H, Dietel M. Effect of the breast cancer resistance protein on atypical multidrug resistance. Lancet Oncol 2000; 1: 16975.
  • 4
    Withoff S, De Jong S, De Vries EG, Mulder NH. Human DNA topoisomerase II: biochemistry and role in chemotherapy resistance. Anticancer Res 1996; 16: 186780.
  • 5
    Scheffer GL, Schroeijers AB, Izquierdo MA, Wiemer EA, Scheper RJ. Lung resistance-related protein/major vault protein and vaults in multidrug-resistant cancer. Curr Opin Oncol 2000; 12: 5506.
  • 6
    Dahl O. Interaction of heat and drugs in vitro and in vivo. In: SeegenschmiedtMH, FessendenP, VernonCC, eds. Thermoradiotherapy and thermochemotherapy. New York: Springer-Verlag, 1995. 10321.
  • 7
    Bozzetti F, Vaglini M, Deraco M. Intraperitoneal hyperthermic chemotherapy in gastric cancer: rationale for a new approach. Tumori 1998; 84: 4838.
  • 8
    Fujimoto S, Takahashi M, Mutou T, Kobayashi K, Toyosawa T. Successful intraperitoneal hyperthermic chemoperfusion for the prevention of postoperative peritoneal recurrence in patients with advanced gastric carcinoma. Cancer 1999; 85: 52934.
  • 9
    Sayag-Beaujard AC, Francois Y, Glehen O, Sadeghi-Looyeh B, Bienvenu J, Panteix G, Garbit F, Grandclement E, Vignal J, Gilly FN. Intraperitoneal chemo-hyperthermia with mitomycin C for gastric cancer patients with peritoneal carcinomatosis. Anticancer Res 1999; 19: 137582.
  • 10
    Pantazis P. Preclinical studies of water-insoluble camptothecin congeners: cytotoxicity, development of resistance, and combination treatments. Clin Cancer Res 1995; 1: 123544.
  • 11
    Dietel M, Arps H, Lage H, Niendorf A. Membrane vesicle formation due to acquired mitoxantrone resistance in human gastric carcinoma cell line EPG85-257. Cancer Res 1990; 50: 61006.
  • 12
    Lage H, Jordan A, Scholz R, Dietel M. Thermosensitivity of multidrug-resistant human gastric and pancreatic carcinoma cells. Int J Hyperthermia 2000; 16: 291303.
  • 13
    Stein U, Lage H, Jordan A, Walther W, Bates SE, Litman T, Hohenberger P, Dietel M. Impact of BCRP/MXR, MRP1 and MDR1/P-glycoprotein on thermoresistant variants of atypical and classical multidrug resistant cancer cells. Int J Cancer 2002; 97: 75160.
  • 14
    Ross DD, Yang W, Abruzzo LV, Dalton WS, Schneider E, Lage H, Dietel M, Greenberger L, Cole SP, Doyle LA. Atypical multidrug resistance: breast cancer resistance protein messenger RNA expression in mitoxantrone-selected cell lines. J Natl Cancer Inst 1999; 91: 42933.
  • 15
    Lage H, Perlitz C, Abele R, Tampé R, Dietel M, Schadendorf D, Sinha P. Enhanced expression of human ABC transporter TAP is associated with cellular resistance to mitoxantrone. FEBS Lett 2001; 503: 17984.
  • 16
    Kellner U, Hutchinson L, Seidel A, Lage H, Danks MK, Dietel M, Kaufmann SH. Decreased drug accumulation in a mitoxantrone-resistant gastric carcinoma cell line in the absence of P-glycoprotein. Int J Cancer 1997; 71: 81724.
  • 17
    Lage H, Dietel M. Cloning and characterization of human cDNAs encoding a protein with high homology to rat intestinal development protein OCI-5. Gene 1997; 188: 1516.
  • 18
    Sinha P, Poland J, Schnölzer M, Celis JE, Lage H. Characterization of the differential protein expression associated with thermoresistance in human gastric carcinoma cell lines. Electrophoresis 2001; 22: 29903000.
  • 19
    Poland J, Schadendorf D, Lage H, Schnölzer M, Celis JE, Sinha P. Study of therapy resistance in cancer cells with functional proteome analysis. Clin Chem Lab Med 2002; 40: 22134.
  • 20
    Tönnies H, Toliat MR, Ramel C, Pape UF, Neitzel H, Berger W, Wiedenmann B. Analysis of sporadic neuroendocrine tumours of the enteropancreatic system by comparative genomic hybridisation. Gut 2001; 48: 53641.
  • 21
    Wasenius VM, Jekunen A, Monni O, Joensuu H, Aebi S, Howell SB, Knuutila S. Comparative genomic hybridization analysis of chromosomal changes occurring during development of acquired resistance to cisplatin in human ovarian carcinoma cells. Genes Chromosomes Cancer 1997; 18: 28691.
  • 22
    Knutsen T, Mickley LA, Ried T, Green ED, du Manoir S, Schrock E, Macville M, Ning Y, Robey R, Polymeropoulos M, Torres R, Fojo T. Cytogenetic and molecular characterization of random chromosomal rearrangements activating the drug resistance gene, MDR1/P-glycoprotein, in drug-selected cell lines and patients with drug refractory ALL. Genes Chromosomes Cancer 1998; 23: 4454.
  • 23
    Carlson KM, Gruber A, Liliemark E, Larsson R, Nordenskjold M. Characterization of drug-resistant cell lines by comparative genomic hybridization. Cancer Genet Cytogenet 1999; 111: 326.
  • 24
    Nessling M, Kern MA, Schadendorf D, Lichter P. Association of genomic imbalances with resistance to therapeutic drugs in human melanoma cell lines. Cytogenet Cell Genet 1999; 87: 28690.
  • 25
    Knutsen T, Rao VK, Ried T, Mickley L, Schneider E, Miyake K, Ghadimi BM, Padilla-Nash H, Pack S, Greenberger L, Cowan K, Dean M, et al. Amplification of 4q21-q22 and the MXR gene in independently derived mitoxantrone-resistant cell lines. Genes Chromosomes Cancer 2000; 27: 1106.
  • 26
    Achuthan R, Bell SM, Roberts P, Leek JP, Horgan K, Markham AF, MacLennan KA, Speirs V. Genetic events during the transformation of a tamoxifen-sensitive human breast cancer cell line into a drug-resistant clone. Cancer Genet Cytogenet 2001; 130: 16672.
  • 27
    Struski S, Doco-Fenzy M, Trussardi A, Masson L, Gruson N, Ulrich E, Proult M, Jardillier JC, Potron G, Cornillet-Lefebvre P. Identification of chromosomal loci associated with non-P-glycoprotein-mediated multidrug resistance to topoisomerase II inhibitor in lung adenocarcinoma cell line by comparative genomic hybridization. Genes Chromosomes Cancer 2001; 30: 13642.
  • 28
    Weber RG, Rieger J, Naumann U, Lichter P, Weller M. Chromosomal imbalances associated with response to chemotherapy and cytotoxic cytokines in human malignant glioma cell lines. Int J Cancer 2001; 91: 2138.
  • 29
    Obara K, Ghazizadeh M, Shimizu H, Arai R, Tenjin T, Suzuki S, Moriyama Y, Kawanami O. Comparative genomic hybridization study of genetic changes associated with vindesine resistance in esophageal carcinoma. Int J Oncol 2002; 20: 25560.
  • 30
    Knuutila S, Bjorkqvist AM, Autio K, Tarkkanen M, Wolf M, Monni O, Szymanska J, Larramendy ML, Tapper J, Pere H, El-Rifai W, Hemmer S, et al. DNA copy number amplifications in human neoplasms: review of comparative genomic hybridization studies. Am J Pathol 1998; 152: 110723.
  • 31
    Knuutila S, Aalto Y, Autio K, Bjorkqvist AM, El-Rifai W, Hemmer S, Huhta T, Kettunen E, Kiuru-Kuhlefelt S, Larramendy ML, Lushnikova T, Monni O, et al. DNA copy number losses in human neoplasms. Am J Pathol 1999; 155: 68394.
  • 32
    Lage H, Dietel M. Involvement of the DNA mismatch repair system in antineoplastic drug resistance. J Cancer Res Clin Oncol 1999; 125: 15665.
  • 33
    Berge KE, Tian H, Graf GA, Yu L, Grishin NV, Schultz J, Kwiterovich P, Shan B, Barnes R, Hobbs HH. Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters. Science 2000; 290: 17715.
  • 34
    Lavie Y, Fiucci G, Liscovitch M. Upregulation of caveolin in multidrug resistant cancer cells: functional implications. Adv Drug Deliv Rev 2001; 49: 31723.
  • 35
    Kojima H, Endo K, Moriyama H, Tanaka Y, Alnemri ES, Slapak CA, Teicher B, Kufe D, Datta R. Abrogation of mitochondrial cytochrome c release and caspase-3 activation in acquired multidrug resistance. J Biol Chem 1998; 273: 1664750.
  • 36
    Yoshida M, Suzuki T, Komiya T, Hatashita E, Nishio K, Kazuhiko N, Fukuoka M. Induction of MRP5 and SMRP mRNA by Adriamycin exposure and its overexpression in human lung cancer cells resistant to Adriamycin. Int J Cancer 2001; 94: 4327.
  • 37
    Kool M, van der Linden M, de Haas M, Scheffer GL, de Vree JM, Smith AJ, Jansen G, Peters GJ, Ponne N, Scheper RJ, Elferink RP, Baas F, et al. MRP3, an organic anion transporter able to transport anti-cancer drugs. Proc Natl Acad Sci USA 1999; 96: 69149.
  • 38
    James M, Crabbe C, Hepburne-Scott HW. Small heat shock proteins (sHSPs) as potential drug targets. Curr Pharm Biotechnol 2001; 2: 77111.
  • 39
    Sinha P, Hutter G, Köttgen E, Dietel M, Schadendorf D, Lage H. Increased expression of epidermal fatty acid binding protein, cofilin, and 14-3-3-sigma (stratifin) detected by two-dimensional gel electrophoresis, mass spectrometry and microsequencing of drug-resistant human adenocarcinoma of the pancreas. Electrophoresis 1999; 20: 295260.
  • 40
    van den Ijssel PR, Overkamp P, Knauf U, Gaestel M, de Jong WW. Alpha A-crystallin confers cellular thermoresistance. FEBS Lett 1994; 355: 546.
  • 41
    Iwaki T, Iwaki A, Tateishi J, Goldman JE. Sense and antisense modification of glial alpha B-crystallin production results in alterations of stress fiber formation and thermoresistance. J Cell Biol 1994; 125: 138593.
  • 42
    Angelidis CE, Lazaridis I, Pagoulatos GN. Constitutive expression of heat-shock protein 70 in mammalian cells confers thermoresistance. Eur J Biochem 1991; 199: 359.
  • 43
    Fortin A, Raybaud-Diogene H, Tetu B, Deschenes R, Huot J, Landry J. Overexpression of the 27 KDa heat shock protein is associated with thermoresistance and chemoresistance but not with radioresistance. Int J Radiat Oncol Biol Phys 2000; 46: 125966.
  • 44
    Sietsma H, Veldman RJ, Kok JW. The involvement of sphingolipids in multidrug resistance. J Membr Biol 2001; 181: 15362.
  • 45
    Johnstone RW, Ruefli AA, Lowe SW. Apoptosis: a link between cancer genetics and chemotherapy. Cell 2002; 108: 15364.